Cognitive & NeuroprotectiveIn StockCognitive & Neuroprotective
Selank
Also known as: TP-7, Tuftsin analog
Synthetic heptapeptide derived from the endogenous tetrapeptide tuftsin; studied in anxiolytic and immunomodulatory research.
Selank is a synthetic heptapeptide developed at the Russian Institute of Molecular Genetics in the 1990s.
Its structure consists of the endogenous immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro tripeptide extension that confers resistance to enzymatic degradation.Research on Selank encompasses anxiolytic signaling (via GABAergic and serotonergic pathways), immune modulation, and neurotrophic-factor regulation including BDNF expression in animal models.
Published studies, predominantly from Russian research groups, have examined Selank in behavioral models of anxiety, stress adaptation, and memory formation.Selank is frequently paired with Semax in nootropic-peptide research, reflecting complementary mechanisms — Selank's primary profile relates to anxiolytic signaling while Semax's focuses on BDNF/NGF upregulation.
Research applications
- GABAergic and serotonergic signaling research
- Anxiolytic peptide pharmacology
- BDNF expression and neurotrophic research
- Immune modulation (tuftsin-derived biology)
- Combination research with Semax in nootropic studies
Technical profile
- Net content
- 10 mg
- Molecular formula
- C33H57N11O9
- Molecular weight
- 751.87 g/mol
- CAS
- 129954-34-3
- Sequence
- Thr-Lys-Pro-Arg-Pro-Gly-Pro
For research use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease. Catalog availability restricted to verified licensed practitioners.
Selank is a synthetic heptapeptide analogue of the immunomodulatory peptide tuftsin. It modulates the expression of BDNF and exhibits anxiolytic and nootropic properties by influencing serotonergic and GABAergic neurotransmitter systems.
